Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2023 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CONCERT PHARMACEUTICALS INC | 16 | Q2 2018 | 4.5% |
SANOFI | 14 | Q2 2018 | 17.6% |
CORIUM INTL INC | 14 | Q3 2017 | 2.3% |
FOAMIX PHARMACEUTICALS LTD | 14 | Q2 2018 | 2.1% |
RETROPHIN INC | 13 | Q2 2017 | 3.0% |
ALDER BIOPHARMACEUTICALS INC | 12 | Q2 2018 | 3.9% |
RIGEL PHARMACEUTICALS INC | 12 | Q3 2016 | 1.8% |
INSMED INC | 11 | Q3 2017 | 6.2% |
TEVA PHARMACEUTICAL INDS LTD | 10 | Q1 2016 | 12.3% |
ORTHOFIX INTL N V | 10 | Q1 2017 | 9.0% |
View SENZAR ASSET MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Corium International, Inc.Sold out | February 14, 2018 | 0 | 0.0% |
Aviragen Therapeutics, Inc. | February 13, 2017 | 1,774,876 | 4.6% |
CONCERT PHARMACEUTICALS, INC. | February 13, 2017 | 400,588 | 1.8% |
Foamix Pharmaceuticals Ltd. | February 13, 2017 | 550,997 | 1.5% |
NEVRO CORPSold out | February 13, 2017 | 0 | 0.0% |
TIVITY HEALTH, INC. | February 13, 2017 | 383,200 | 1.0% |
HEALTHWAYS, INC | February 12, 2016 | 2,525,044 | 7.0% |
Sientra, Inc. | February 12, 2016 | 580,851 | 3.2% |
Biota Pharmaceuticals, Inc. | January 15, 2016 | 2,025,976 | 5.2% |
View SENZAR ASSET MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-10-31 |
13F-HR | 2018-08-13 |
13F-HR | 2018-05-14 |
SC 13G/A | 2018-02-14 |
13F-HR | 2018-02-13 |
13F-HR | 2017-11-13 |
13F-HR | 2017-08-11 |
13F-HR | 2017-05-12 |
13F-HR | 2017-02-14 |
SC 13G/A | 2017-02-13 |
View SENZAR ASSET MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.